Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;31(3):125-9.
doi: 10.1002/clc.20210.

Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease

Affiliations

Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease

Chiara Melloni et al. Clin Cardiol. 2008 Mar.

Abstract

Background: The prognostic value of cardiac troponins (cTn) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) and chronic kidney disease (CKD) is debated.

Hypothesis: We tested the performance of cTnI and cTnT for risk stratification in patients with CKD and evaluated the prognostic significance of cTnI and cTnT elevations by their magnitude across the range of CKD severity.

Methods: We examined correlations among cTn elevation, CKD, and in-hospital mortality in 31,586 high-risk patients with NSTE ACS included in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines initiative (CRUSADE). Cardiac tropinins I and T levels were categorized as ratios of each site's upper limit of normal (ULN) for myocardial necrosis: normal (cTn ratio < or =1 x ULN), mild (cTn ratio > 1-3 x ULN), and major (cTn ratio > 3 x ULN) elevation. Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease equation. Stages of CKD were categorized as normal to mild (eGFR > 60 mL/min), moderate (eGFR 30-60 mL/min), or severe (eGFR < 30 mL/min).

Results: Mortality increased more steeply across CKD stages (2.0%-12.9%) than across cTn ratio categories (2.7%-5.4%). In normal or mild CKD, mortality was low regardless of cTn elevations. In moderate CKD, mortality increased incrementally with cTnI (3.3% versus 5.4% versus 7.4%) and cTnT (3.7% versus 5.3% versus 7.3%) elevation. Among severe CKD patients, only major cTn elevations further distinguished risk (cTnI: 10.1% versus 9.7% versus 14.6%; cTnT: 7.0% versus 5.7% versus 14.0%).

Conclusions: In patients with CKD, cTnI and cTnT perform equally in differentiating short-term prognosis following NSTE ACS; however, the prognostic impact of cTn is dependent upon the degree of CKD severity.

PubMed Disclaimer

References

    1. Newby LK, Goldmann BU, Ohman EM: Troponin: an important prognostic marker and risk‐stratification tool in non‐ST‐segment elevation acute coronary syndromes. J Am Coll Cardiol 2003; 41: S31–S36. - PubMed
    1. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, et al.: GUSTO‐IIb, GUSTO‐III, PURSUIT. Global use of strategies to open occluded coronary arteries. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy; PARAGON‐A investigators. Platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a global organization network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106(8): 974–980. - PubMed
    1. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, et al., TIMI Study Group: Association of glomerular filtration rate on presentation with subsequent mortality in non‐ST‐segment elevation acute coronary syndrome; observations in 13,307 patients in 5 TIMI trials. Eur Heart J 2004; 25(22): 1998–2005. - PubMed
    1. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, et al.: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351(13): 1285–1295. - PubMed
    1. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW: Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43(6 Pt. 1): 976–982. - PubMed

Publication types